Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Equity Ratio (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Equity Ratio for 16 consecutive years, with 0.64 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Equity Ratio rose 26.18% year-over-year to 0.64, compared with a TTM value of 0.64 through Sep 2025, up 26.18%, and an annual FY2024 reading of 0.55, up 34.87% over the prior year.
  • Equity Ratio was 0.64 for Q3 2025 at Rockwell Medical, up from 0.58 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.64 in Q3 2025 and bottomed at 0.13 in Q1 2022.
  • Average Equity Ratio over 5 years is 0.36, with a median of 0.38 recorded in 2021.
  • Peak annual rise in Equity Ratio hit 479.59% in 2022, while the deepest fall reached 134.07% in 2022.
  • Year by year, Equity Ratio stood at 0.05 in 2021, then skyrocketed by 479.59% to 0.3 in 2022, then surged by 34.91% to 0.41 in 2023, then skyrocketed by 34.87% to 0.55 in 2024, then grew by 17.01% to 0.64 in 2025.
  • Business Quant data shows Equity Ratio for RMTI at 0.64 in Q3 2025, 0.58 in Q2 2025, and 0.58 in Q1 2025.